The inhibitory effect of matrix metalloproteinase inhibitor ONO-4817 on lymph node metastasis in tongue carcinoma

Anticancer Research

Volumn 23, Issue 3 B, 2003, Pages 2297-2302

  Yamashita, Taku ^a   Fujii, Masato ^a   Tomita, Toshiki ^a   Ishiguro, Ryuichiro ^a   Tashiro, Masatsugu ^a   Tokumaru, Yutaka ^a   Imanishi, Yorihisa ^a   Kanke, Minoru ^a   Ogawa, Kaoru ^a   Kameyama, Kaori ^a   Otani, Yoshihide ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Head and neck squamous cell carcinoma; Lymph node metastasis; Matrix metalloproteinase inhibitor; ONO 4817; Orthotopic implantation model

Indexed keywords

5 ETHOXYMETHOXY N HYDROXY 2 METHYL 4 (4 PHENOXYBENZAMIDO)PENTANAMIDE; GELATINASE B; MATRIX METALLOPROTEINASE INHIBITOR; N HYDROXY 5 ETHOXYMETHYLOXY 2 METHYL 4 (4 PHENOXYBENZOYL)AMINOPENTAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; FILM; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TONGUE CARCINOMA; ZYMOGRAPHY;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; COLLAGENASES; ENZYME PRECURSORS; HUMANS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; PHENYL ETHERS; TONGUE NEOPLASMS; TUMOR CELLS, CULTURED; WEIGHT LOSS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0042306604     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Woolgar JA, Rogers S, West CR, Errington RD, Brown JS and Vaughan ED: Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. Oral Oncol 35: 257-265, 1999.
2. Li XM, Wei WI, Guo XF, Yuen PW and Lam LK: Cervical lymph node metastatic patterns of squamous carcinomas in the upper aerodigestive tract. J Laryngol Otol 110: 937-941, 1996.
3. Snow GB, van den Brekel MW, Leemans CR and Patel P: Surgical management of cervical lymph nodes in patients with oral and oropharyngeal cancer. Recent Results Cancer Res 134: 43-55, 1994.
4. Oba K, Konno H, Tanaka T, Baba M, Kamiya K, Ohta M, Kaneko T, Shouji T, Igarashi A and Nakamura S: Prevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166. Cancer Lett 175: 45-51, 2002.
5. Maekawa R, Maki H, Wada T, Yoshida H, Nishida-Nishimoto K, Okamoto H, Matsumoto Y, Tsuzuki H and Yoshioka T: Antimetastatic efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor. Clin Exp Metastasis 18: 61-66, 2000.
6. Jimenez RE, Hartwig W, Antoniu BA, Compton CC, Warshaw AL and Fernandez-Del CC: Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: an additive strategy for cancer control. Ann Surg 231: 644-654, 2000.
7. Bu W, Tang ZY, Sun FX, Ye SL, Liu KD, Xue Q, Chen J and Gao DM: Effects of matrix metalloproteinase inhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic model LCI-D20. Hepatogastroenterology 45: 1056-1061, 1998.
8. Sledge GW Jr, Qulali M, Goulet R, Bone EA and Fife RJ: Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Inst 87: 1546-50, 1995.
9. Otani Y, Kubota T, Sakurai Y, Igarashi N, Yokoyama T, Kimata M, Wada N, Kameyama K, Kumai K, Okada Y and Kitajima M: Expression of matrix metalloproteinases in gastric carcinoma and possibility of clinical application of matrix metalloproteinase inhibitor in vivo. Ann N Y Acad Sci 30: 541-543, 1999.
10. Igarashi N, Kubota T, Otani Y, Matsuzaki SW, Watanabe M, Teramoto T, Kumai K, Tamaki K, Tanzawa K, Kobayashi T and Kitajima M: Preventive effect of matrix metalloproteinase inhibitor, R-94138, in combination with mitomycin C or cisplatin on peritoneal dissemination of human gastric cancer cell line TMK-1 in nude mice. Jpn J Cancer Res 90: 116-121, 1999.
11. Matsuoka T, Yashiro M, Sawada T, Ishikawa T, Ohira M and Hirakawa-YS Chung K: Inhibition of invasion and lymph node metastasis of gastrointestinal cancer cells by R-94138, a matrix metalloproteinase inhibitor. Anticancer Res 20: 4331-4338, 2000.
12. Matsui T, Ota T, Ueda Y, Tanino M and Odashima S: Isolation of a highly metastatic cell line to lymph node in human oral squamous cell carcinoma by orthotopic implantation in nude mice. Oral Oncol 34: 253-256, 1998.
13. Shimada T, Nakamura H, Yamashita K, Kawata R, Murakami Y, Fujimoto N, Sato H, Seiki M and Okada Y: Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis. Clin Exp Metastasis 18: 179-188, 2000.
14. Hong SD, Hong SP, Lee JI and Lim CY: Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncol 36: 207-213, 2000.
15. O-Charoenrat P, Rhys-Evans PH and Eccles SA: Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127: 813-820, 2001.
16. Horikawa T, Yoshizaki T, Sheen TS, Lee SY and Furukawa M: Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma. Cancer 89: 715-23, 2000.
17. Du B, Wang P, Guo X and Du B: Expression of membrane type 1-matrix metalloproteinase in laryngeal carcinoma. Pathol Oncol Res 5: 214-217, 1999.
18. Tokumaru Y, Fujii M, Otani Y, Kameyama K, Imanishi Y, Igarashi N and Kanzaki J: Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma: studies of clinical samples and in vitro cell lines co-cultured with fibroblasts. Cancer Lett 150: 15-21, 2000.
19. Imanishi Y, Fujii M, Tokumaru Y, Tomita T, Kanke M, Kanzaki J, Kameyama K, Otani Y and Sato H: Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Hum Pathol 31: 895-904, 2000.
20. Yamada A, Uegaki A, Nakamura T and Ogawa K: ONO-4817, an orally active matrix metalloproteinase Inhibitor, prevents lipopolysaccharide-induced proteoglycan release from the joint cartilage in guinea pigs. Inflamm Res 49: 144-146, 2000.
21. Talbot DC and Brown PD: Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer. Eur J Cancer 32A: 2528-2533, 1996.
22. Muraishi Y, Mitani N, Fuse H and Saiki I: Effect of a matrix metalloproteinase inhibitor (ONO-4817) on lung metastasis of murine renal cell carcinoma. Anticancer Res 21: 3845-3852, 2001.
23. Oh-e H, Tanaka S, Kitadai Y, Shimamoto F, Yoshihara M and Haruma K: Angiogenesis at the site of deepest penetration predicts lymph node metastasis of submucosal colorectal cancer. Dis Colon Rectum 44: 1129-1136, 2001.
24. Wakisaka N, Wen OH, Yoshizaki T, Nishimura T, Furukawa M, Kawahara E and Nakanishi M: Association of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinoma. Laryngoscope 109: 810-814, 1999.
25. Wang X, Fu X, Brown PD, Crimmin MJ and Hoffman RM: Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res 54: 4726-8, 1994.
26. Low JA, Johnson MD, Bone EA and Dickson RB: The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice. Clin Cancer Res 2: 1207-1214, 1996.
27. Anderson IC, Shipp MA, Docherty AJP and Teicher BA: Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma. Cancer Res 56: 715-718, 1996.
28. Conway JG, Trexler SJ, Wakefield JA, Marron BE, Emerson DL, Bickett DM, Deaton DN, Garrison D, Elder M, McElroy A, Willmott N, Dockerty AJ and McGeehan GM: Effect of matrix metalloproteinase inhibitors on tumor growth and spontaneous metastasis. Clin Exp Metastasis 14: 115-124, 1996.